Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (24)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Tang, O. S.
Right arrow Articles by Ho, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tang, O. S.
Right arrow Articles by Ho, P. C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 18, No. 1, 176-181, January 2003
© 2003 European Society of Human Reproduction and Embryology

A prospective randomized study to compare the use of repeated doses of vaginal with sublingual misoprostol in the management of first trimester silent miscarriages

Oi Shan Tang1, Winnie Nga Ting Lau, Ernest Hung Yu Ng, Sharon Wai Heung Lee and Pak Chung Ho

Department of Obstetrics and Gynaecology, The University of Hong Kong, Queen Mary Hospital, Hong Kong SAR, China 1 To whom correspondence should be addressed at: 6/F, Professorial Block, Department of Obstetrics and Gynaecology, The University of Hong Kong, Queen Mary Hospital, 102, Pokfulam Road, Hong Kong SAR, China. e-mail: ostang{at}graduate.hku.hk

BACKGROUND: A randomized controlled trial comparing sublingual with vaginal administration of misoprostol for medical management of silent miscarriages. METHODS: Eighty women who had silent miscarriages (<13 weeks) were randomized to receive 600 µg of misoprostol every 3 h for a maximum of three doses either sublingually or vaginally. RESULTS: The success rates of medical management were the same in both groups (87.5%; 95% CI: 74–95%). There were no serious complications. The incidence of diarrhoea was higher in the sublingual (70%) than the vaginal route (27.5%) (P < 0.005). Other side effects were similar in each group, although fatigue was experienced by more women in the sublingual group than in the vaginal group (65 versus 40%: P = 0.043). The overall acceptability of medical management was good. Most women would choose the medical method if they were allowed to choose again and would recommend the method to others. CONCLUSION: The current regimen of misoprostol is useful for the management of silent miscarriage in terms of complete miscarriage rate and patient acceptability. Sublingual misoprostol may offer an alternative for women who do not like repeated vaginal administration of the drug.

Key words: first trimester/misoprostol/miscarriages/sublingual/vaginal


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
The Obstetrician and GynaecologistHome page
H. Sagili and M. Divers
Modern management of miscarriage
Obstet Gynaecol (Lond), April 1, 2007; 9(2): 102 - 108.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
A. Weeks and K. G. Danielsson
Spontaneous miscarriage in the first trimester.
BMJ, May 27, 2006; 332(7552): 1223 - 1224.
[Full Text] [PDF]


Home page
Hum ReprodHome page
O. S. Tang, C. Y.T. Ong, K. Y. Tse, E. H.Y. Ng, S. W.H. Lee, and P. C. Ho
A randomized trial to compare the use of sublingual misoprostol with or without an additional 1 week course for the management of first trimester silent miscarriage
Hum. Reprod., January 1, 2006; 21(1): 189 - 192.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
W. H. Tam, M. H. Y. Tsui, I. H. Lok, S.-K. Yip, P. M. Yuen, and T. K. H. Chung
Long-term reproductive outcome subsequent to medical versus surgical treatment for miscarriage
Hum. Reprod., December 1, 2005; 20(12): 3355 - 3359.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. H.S. You and T. K.H. Chung
Expectant, medical or surgical treatment for spontaneous abortion in first trimester of pregnancy: a cost analysis
Hum. Reprod., October 1, 2005; 20(10): 2873 - 2878.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. Zhang, J. M. Gilles, K. Barnhart, M. D. Creinin, C. Westhoff, M. M. Frederick, and the National Institute of Child Health !Human Deve
A Comparison of Medical Management with Misoprostol and Surgical Management for Early Pregnancy Failure
N. Engl. J. Med., August 25, 2005; 353(8): 761 - 769.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
B. Winikoff
Pregnancy Failure and Misoprostol -- Time for a Change
N. Engl. J. Med., August 25, 2005; 353(8): 834 - 836.
[Full Text] [PDF]


Home page
Hum ReprodHome page
O. S. Tang, K. H. Mok, and P. C. Ho
A randomized study comparing the use of sublingual to vaginal misoprostol for pre-operative cervical priming prior to surgical termination of pregnancy in the first trimester
Hum. Reprod., May 1, 2004; 19(5): 1101 - 1104.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J.S. Bagratee, V. Khullar, L. Regan, J. Moodley, and H. Kagoro
A randomized controlled trial comparing medical and expectant management of first trimester miscarriage
Hum. Reprod., February 1, 2004; 19(2): 266 - 271.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.